Big-data analysis: A clinical pathway on endoscopic retrograde cholangiopancreatography for common bile duct stones

doi:10.3748/wjg.v25.i8.1002

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7911)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

471

WORD

361

HTML

4136

Figures (1-1)

175

Tables (1-5)

171

Sum=5314

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

804

Download

1793

Sum=2597

Feb 28, 2019 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Feb 28, 2019; 25(8): 1002-1011
Published online Feb 28, 2019. doi: 10.3748/wjg.v25.i8.1002

Table 1 Demographic and clinical characteristics of patients

Characteristic	Non-pathway group (n = 467)	Cinical pathway group (n = 2196)	P value
Age, yr (median, range)	64 (52-75)	63 (51-75)	0.405
Female, n (%)	235 (50.32)	1093 (49.77)	0.829
Medical insurance, n (%)	217 (46.47)	945 (43.03)	0.174
Health behavior, n (%)
Smoking	57 (12.21)	260 (11.84)	0.825
Alcohol use	36 (7.71)	164 (7.47)	0.858
Comorbidity, n (%)
Hypertension	155 (33.19)	703 (32.01)	0.621
Diabetes	68 (14.56)	292 (13.30)	0.468
COPD	11 (2.36)	54 (2.46)	0.895
Myocardial infarction	0	6 (0.27)	0.258
Cholangitis	74 (15.85)	271 (12.34)	0.041^a
Cholecystolithiasis	188 (40.26)	780 (35.52)	0.053
JPD	1 (0.21)	10 (0.46)	0.460
CBD stone number ≥ 5, n (%)	201 (43.04)	1173 (53.42)	< 0.001^a
Maximum diameter of stones, cm (median, range)	0.8 (0.6-1.2)	0.9 (0.6-1.2)	0.949
Laboratory test (median, range)
Temperature (°C), n = 359/2113	36.5 (36.3-36.8)	36.5 (36.3-36.8)	0.855
WBC count, n = 370/1451	6.0 (4.7-9.2)	5.7 (4.6-7.6)	0.005^a
Direct bilirubin level, n = 363/1439	12.2 (5.6-44.2)	10.7 (4.8-37.2)	0.210
Total bilirubin level, n = 363/1439	22.6 (12.7-57.6)	21.2 (12.5-51.9)	0.628
AST, n = 363/1440	47.9 (22.8-104.5)	45.4 (23.5-104.8)	0.842
GGT, n = 363/1439	257.4 (115.3-492.4)	265.1 (109.9-519.4)	0.918
ALP, n = 363/1439	161.7 (99.9-283.3)	154.9 (97.4-259.3)	0.536
ALT, n = 364/1443	85.1 (29.6-203.2)	89.0 (32.0-206.9)	0.946
Cr, n = 361/1431	62.0 (52.0-74.0)	62.0 (2.0-73.0)	0.966

^aP < 0.05 was considered statistically significant.

COPD: Chronic obstructive pulmonary disease; JPD: Juxtapapillary duodenal diverticulum; CBD stones: Common bile duct stones; WBC: White blood cell; AST: Aspartate transaminase; GGT: Gamma-glutamyl transpeptidase; ALP: Alkaline phosphatase; Cr: Creatinine.

Table 2 Comparison of length of hospital stay, clinical outcomes, hospital charges, and drug use between the non-pathway and clinical pathway groups

Characteristic	Non-pathway group (n = 467)	Cinical pathway group (n = 2196)	P value
Length of total hospital stay (median, range)	8 (6-11)	7 (5-9)	< 0.001^a
Pre-operative length of stay	2 (1-4)	2 (1-3)	0.451
Readmission, n (%)	34 (7.28)	173 (7.88)	0.661
Clinical outcomes, n (%)			0.115
Recovered	223 (47.75)	1146 (52.19)
Improved	236 (50.54)	1028 (46.81)
Not improved	8 (1.71)	22 (1)
Died	0	0
Charges of hospitalization (CNY), (median, range) n = 467/2183	21508.3 (17150.6-30045.8)	18362.9 (15665.8-22895.2)	< 0.001^a
Charges of medication, n = 459/2153	6620.6 (3429.4-12239.7)	4900.6 (3172.4-8186.0)	< 0.001^a
Charges of operation, n = 458/2151	5741.0 (4519.2-7324.0)	5455.2 (2670.0-6964.0)	< 0.001^a
Charges of nursing, n = 454/2133	188.0 (115.0-288.0)	120.0 (74.0-211.0)	< 0.001^a
Charges of materials, n = 409/1540	7916.4 (6696.0-10552.6)	6985.5 (6135.1-8224.7)	< 0.001^a
Charges of examination, n = 459/2153	2698.0 (2224.5-3799.5)	2463.5 (2134.5-3105.5)	< 0.001^a
Antibiotic use, n (%)	260/430 (60.47)	832/1737 (47.90)	< 0.001^a
Antibiotic usage duration (d) (median, range), n = 260/832	12 (8.0-18.5)	11 (7.0-17.0)	0.004^a
Three line antibiotic use, n (%)	51/430 (11.86)	149/1737 (8.58)	0.035^a
Secondary surgery, n (%)	69 (14.78)	372 (16.94)	0.253

^aP < 0.05 was considered statistically significant.

Table 3 Comparison of postoperative complication rates between the non-pathway and clinical pathway groups

Characteristic	Non-pathway group (n = 467)	Cinical pathway group (n = 2196)	P value
Total, n (%)	125 (26.77)	316 (14.39)	< 0.001^a
Acute pancreatitis	113 (24.20)	298 (13.57)	< 0.001^a
Gallbladder perforation	1 (0.21)	1 (0.05)	0.227
Gastrointestinal hemorrhage	0	2 (0.09)	0.514
Biliary tract infection	2 (0.43)	4 (0.18)	0.308
Liver abscess	10 (2.14)	11 (0.50)	< 0.001^a

^aP < 0.05 was considered statistically significant.

Table 4 Univariate logistic regression analysis of outcomes

Characteristic	Non-pathway group (n = 467)	Cinical pathway group (n = 2196)	OR (95%CI)		P value
Length of total hospital stay (median, range)	8 (6-11)	7 (5-9)			< 0.001^a
Pre-operative length of stay	2 (1-4)	2 (1-3)			0.078
Readmission, n (%)	34 (7.28)	173 (7.88)	1.09 (0.74, 1.60)		0.661
Clinical outcomes, n (%)			1.21 (0.99, 1.47)		0.064
Charges of hospitalization (CNY) (median, range)	21508.3 (17150.6-30045.8)	18362.9 (15665.8-22895.2)			< 0.001^a
Medication	6620.6 (3429.4-12239.7)	4900.6 (3172.4-8186.0)			< 0.001^a
Operating	5741.0 (4519.2-7324.0)	5455.2 (2670.0-6964.0)			< 0.001^a
Nursing	188.0 (115.0-288.0)	120.0 (74.0-211.0)			< 0.001^a
Materials	7916.4 (6696.0-10552.6)	6985.5 (6135.1-8224.7)			< 0.001^a
Examination	2698.0 (2224.5-3799.5)	2463.5 (2134.5-3105.5)			< 0.001^a
Antibiotic use, n (%)	260/430 (60.47)	832/1737(47.90)	0.60 (0.49, 0.75)		< 0.001^a
Antibiotic usage duration (d) (median, range)	12 (8.0-18.5)	11 (7.0-17.0)			0.310
Three line antibiotic use, n (%)	51/430 (11.86)	149/1437 (8.58)		0.69	0.036^a
Secondary surgery, n (%)	69 (14.78)	372 (16.94)		1.18	0.254
Complications	125 (26.77)	316 (14.39)		0.46 (0.36, 0.58)	< 0.001^a

^aP < 0.05 was considered statistically significant. OR: Odds ratio; CI: Confidence interval.

Table 5 Multivariate logistic and linear regression analysis of outcomes

Characteristic	Adjusted OR (95%CI) or coefficients	P value
Length of total hospital stay	-1.71 (-2.30, -1.12)¹	< 0.001^a
Hospitalization costs	-5572.26 (-6931.48, -4213.03)¹	< 0.001^a
Medication costs	-2760.03 (-3738.96, -1781.11)¹	< 0.001^a
Operating costs	-382.08 (-635.30, -128.85)¹	< 0.001^a
Nursing costs	-138.25 (-195.83, -80.66)¹	< 0.001^a
Materials costs	-1688.35 (-2049.61, -1327.10)¹	< 0.001^a
Examination costs	-138.25 (-195.83, -80.66)¹	< 0.001^a
Three line antibiotic use	0.89 (0.60, 1.31)	0.546
Antibiotic use, n (%)	0.72 (0.55, 0.93)	0.012^a
Complications	0.44 (0.33, 0.59)	< 0.001^a

¹Coefficients.

^aP < 0.05 was considered statistically significant, adjusted for age, gender, smoking, alcohol use, the number of stones, and white blood cell count at hospital admission.

OR: Odds ratio; CI: Confidence interval.

Citation: Zhang W, Wang BY, Du XY, Fang WW, Wu H, Wang L, Zhuge YZ, Zou XP. Big-data analysis: A clinical pathway on endoscopic retrograde cholangiopancreatography for common bile duct stones. World J Gastroenterol 2019; 25(8): 1002-1011
URL: https://www.wjgnet.com/1007-9327/full/v25/i8/1002.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i8.1002